[Clinical use of HIV-1 resistance genotyping. Predictive factors of poor virological evolution in salvage treatments].

OBJECTIVES To describe the use of genotype resistance testing (GRT) for virological failure in clinical practice, and the long-term clinical and virological evolution in patients for whom it is requested. To identify the predictive factors of virological failure in patients with antiretroviral (ARV) salvage therapy. METHODS Observational study in HIV… CONTINUE READING